GLP-/GIP dual agonist innovatively integrates the effects of two incretin into one molecule, which can simultaneously activate GLP-1R and GIPR
Our strategies can support brain, hormonal and gut health to promote an improved quality of life
However, for qualified patients, they may help support appetite control, earlier fullness, reduced food intake, and greater consistency with a medical weight-loss plan
In contrast, long-term management relies on medications like ulipristal acetate, IUDs, and symptomatic treatment, with ongoing monitoring
Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature
MedImpact has announced the launch of GLP-1 Benefit 360 and GLP-1 Direct Fund, aimed at addressing inefficiencies in the drug supply chain while managing the skyrocketing demand for weight management therapies